Skip to main content

#162059

Anti-deltaNp63 [PANp63-6.1]

Cat. #162059

Anti-deltaNp63 [PANp63-6.1]

Cat. #: 162059

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: tumour protein p63 lacking the transactivation domain (TA)

Class: Monoclonal

Reactivity: Human ; mouse ; rat

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Moravian Biotechnology

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-deltaNp63 [PANp63-6.1]
  • Clone: PANp63-6.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 72-76 kDa (variable, depending on the p63 isoform present)
  • Reactivity: Human ; mouse ; rat
  • Host: Mouse
  • Description: Antibody created to detect the deltaN isoform of p63 (deltaNp63) with tumour suppressor role and differentiate from the TA (TAp63) isoforms of the same protein. Binding specificity: Epitope mapping using phage display identified the epitope PSHLIR, which occurs twice within the central region of p63. The antibody recognizes TAp63 and deltaNp63. The antibody does not cross-react with p53 or any p73 isoform tested.
  • Immunogen: PSHLIR sequence of tumour protein p63 (deltaN isoform)
  • Isotype: IgG1 kappa
  • Production details: B cell donor: Splenocytes from mouse immunised with recombinant TAp63?, Fusion partner: SP2

Target Details

  • Target: tumour protein p63 lacking the transactivation domain (TA)
  • Molecular weight: 72-76 kDa (variable, depending on the p63 isoform present)
  • Target background: p63 is a transcription factor of the p53 gene family, encoded by the TP63 gene located at chromosome 3q28. p63 exists as N-terminal isoforms that either contain (TAp63) or lack (deltaNp63) the p53-like transactivation domain at the N-terminus. C-terminal isoforms are produced by alternative splicing of 3' exons. TAp63 is involved in germ cell maintenance and myocyte differentiation, and is expressed in some lymphocytes and lymphomas/leukemias.
  • Epitope sequence: PSHLIR

Handling

  • Format: Liquid
  • Shipping conditions: Dry ice

References

  • Nekulova et al. 2013. Virchows Arch. Sep:463(3):415-25. PMID: 23887585
  • Liu et al. 2020. J Pathol Clin Res. Jan:6(1):83-93. PMID: 31591823
  • Galoczova et al. 2021. Virchows Arch. Apr:478(4):627-636. PMID: 33037932
  • Stenckova et al. 2023. Neoplasma Oct:70(5):621-632. PMID: 38053383

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.